IGFBP3 and pancreatic ductal adenocarcinoma: Elevated IGFBP3 expression correlates with poor prognosis of pancreatic ductal adenocarcinoma, breast cancer, oral squamous cell carcinoma, papillary thyroid carcinoma and colorectal cancer [45, 54, 68–72].